Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verubulin + Temozolomide in Metastatic Melanoma
NCT00609011Phase 2Completed
- Sponsor
- Myrexis, Inc.
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verubulin in melanoma, sponsored by Myrexis, Inc.. Started Mar 2008; status: completed.
02
Drugs
verubulin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00609011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609011.